Page 26 - Read Online

Cancer 2008;8:755-68. curcumin, the anti-inflammatory agent, against neurodegenerative,
11. Ailles LE, Weissman IL. Cancer stem cells in solid tumours. Curr cardiovascular, pulmonary, metabolic, autoimmune and neoplastic
Opin Biotechnol 2007;18:460-6. diseases. Int J Biochem Cell Biol 2009;41:40-59.
12. Gerald JP. Cancer Stem Cells and Novel Targets for Antitumor 33. Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB.
Strategies. Current Pharmaceutical Design 2012;18:2838-49. Bioavailability of curcumin: problems and promises. Molecular
13. Sordillo PP, Helson L. Curcumin and cancer stem cells: curcumin Pharmaceutics 2007;4:807-18.
has asymmetrical effects on cancer and normal stem cells. 34. Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects
Anticancer Res 2015;35:599-614. of curcumin. Curr Pharm Des 2013;19:2032-46.
14. Kundu JK, Surh YJ. Emerging avenues linking inflammation and 35. Li Y, Zhang T. Targeting cancer stem cells by curcumin and clinical
cancer. Free Radic Biol Med 2012;52:2013-37. applications. Cancer Lett 2014;346:197-205.
15. Rebucci M, Michiels C. Molecular aspects of cancer cell resistance 36. Vaidya AA, Sharma MB, Kale VP. Suppression of p38-stress kinase
to chemotherapy. Biochem Pharmacol 2013;85:1219-26. sensitizes quiescent leukemic cells to anti-mitotic drugs by inducing
16. She M, Niu X, Chen X , Li J, Zhou M, He Y, Le Y, Guo K. Resistance proliferative responses in them. Cancer Biol Ther 2008;7:1232-40.
of leukemic stem-like cells in AML cell line KG1a to natural killer 37. Weir NM, Selvendiran K, Kutala VK,Tong L, Vishwanath
cell-mediated cytotoxicity. Cancer Lett 2012;318:173-9. S,Rajaram M, Tridandapani S, Anant S, Kuppusamy P. Curcumin
17. Sak K. Chemotherapy and dietary phytochemical agents. Chemother induces G2/M arrest and apoptosis in cisplatin-resistant human
Res Pract 2012;2012:282570. ovarian cancer cells by modulating akt and p38 mAPK. Cancer Biol
18. Venkatraman P. Specificity in the interaction of natural products Ther 2007;6:178-84.
with their target proteins- a biochemical and structural insight. Mini 38. Pillai GR, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E.
Rev Med Chem 2010;10:540-9. Induction of apoptosis in human lung cancer cells by curcumin.
19. Li Y, Zhang T. Targeting cancer stem cells by curcumin and clinical Cancer Lett 2004;208:163-70.
applications. Cancer Lett 2014;346:197-205. 39. Trepstra W, Pleomachen RE, Prins A, Lom K, Pouwels K, Wognum
20. Zhou H, Beevers CS, Huang S. Targets of curcumin. Current Drug AW, Wagemaker G, Löwenberg B, Wielenga JJ. Fluorouracil
Targets 2011;12:332-47. selectively spares acute myeloid leukemia cells with long term
21. Sarkar FH, Li Y, Wang Z, Padhye S. Lesson learned from nature growth abilities in immunodeficient mice and in culture. Blood
for the development of novel anti-cancer agents: implication of 1996;88:1944-50.
isoflavone, curcumin, and their synthetic analogs. Curr Pharm Des 40. Burney S, Caulfield JL, Niles JC, Wishnok JC, Tannenbaum SR.
2010;16:1801-12. The chemistry of DNA damage from nitric oxide and peroxynitrite.
22. Dikmen M, Canturk Z, Ozturk Y, Tunal Y. Investigation of the Mutat Res 1999;424:37-49.
apoptotic effect of curcumin in human leukemia HL-60 cells by 41. Wei T, Chen C, Hou J, Xin W, Mori A. Nitric oxide induces
using flow cytometry. Cancer Biother Radiopharm 2010;25:749-55. oxidative stress and apoptosis in neuronal cells. Biochim Biophys
23. Taraphdar AK, Roy M, Bhattacharya RK. Natural products Acta 2000;1498:72-9.
as inducers of apoptosis: Implication for cancer therapy and 42. Chandra J, Samali A, Orrenius S. Triggering and modulation of
prevention. Current Sci 2001;80:1387-96. apoptosis by oxidative stress. Free Radic Biol Med 2000;29:323-33.
24. Su CC, Lin JG, Li TM, Chung JG, Yang JS, Ip SW, Lin WC, Chen 43. Bories PN, Bories C. Nitrate determination in biological fluids by
GW. Curcumin-induced apoptosis of human colon cancer colo 205 an enzymatic one-step assay with nitrate reductase. Clin Chem
cells through the production of ROS, Ca2+ and the activation of 1995;41:904-7.
caspase-3. Anticancer Res 2006;26:4379-89. 44. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG.
25. Pae HO, Jeong SO, Jeongc GS,Kim KM, Kim HS, Kim SA, A fluorometric assay for the measurement of nitrite in biological
Kim YC, Kang SD, Kim BN, Chung HT. Curcumin induces pro- samples. Anal Biochem 1993;214:11-6.
apoptotic endoplasmic reticulum stress in human leukemia HL-60 45. Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B. The role
cells. Biochem Biophys Res Commun 2007;353:1040-5. of mitochondria in pharmacotoxicology: a reevaluation of an old,
26. Fong D, Yeh A, Naftalovich R, Choi HT, Chan MM. Curcumin newly emerging topic. Am J Physiol Cell Physiol 2007;293:C12-21.
inhibits the side population (SP) phenotype of the rat C6 glioma cell 46. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE.
line: towards targeting of cancer stem cells with phytochemicals. Mitochondria and reactive oxygen species. Free Radic Biol Med
Cancer Lett 2010;293:65-72. 2009;47:333-43.
27. Kakarala M, Brenner DE, Khorkaya H, Cheng C, Tazi K, Ginestier 47. Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite
C, Liu S, Dontu G, Wicha MS. Targeting breast stem cells with reactions and formation in mitochondria. Free Radic Biol Med
the cancer preventive compounds curcumin and piperine. Breast 2002;33:1451-64.
Cancer Res Treat 2010;122:777-85. 48. Brookes PS,Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium,
28. Hu Y,Fu L. Targeting cancer stem cells: a new therapy to cure ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol
cancer patients. Am J Cancer Res 2012;2:340-56. Cell Physiol 2004;287:C817-33.
29. Gulcur E. Targeting breast cancer stem cells with the curcumin 49. Carbone DL, Doorn JA, Kiebler Z, Petersen DR. Cysteine
nanomedicine [thesis]. University of Illinios, Chicago;2012. modification by lipid peroxidation products inhibits protein
30. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: disulfide isomerase. Chem Res Toxicol 2005;18:1324-31.
from ancient medicine to current clinical trials. Cell Mol Life Sci 50. Salvioli S, Sikora E, Cooper EL, and Franceschi C. Curcumin in
2008;65:1631-52. cell death processes: a challenge for cam of age-related pathologies.
31. Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary Evid Based Complement Alternat Med 2007;4:181-90.
polyphenols: promising role for epigenetics. Biochem Pharmacol 51. Sharma RA, Strimpakos AS. Curcumin: Preventive and therapeutic
2010;80:1771-92. properties in laboratory studies and clinical trials. Antioxid Redox
32. Aggarwal BB, Harikumar KB. Potential therapeutic effects of Signal 2008;10:511-45.

252
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ July 8, 2016 ¦